Clinical trial
Safety and Effectiveness of Flaxseed for Reducing High Cholesterol
NCT00051415 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00051415 |
|---|---|
| Title | Safety and Effectiveness of Flaxseed for Reducing High Cholesterol |
| Official title | A Double Blind, Randomized, Placebo Controlled Trial of Flaxseed in Patients With Hypercholesterolemia |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Behavioral |
| Interventions | Flaxseed-supplemented diet |
| Enrollment | 60 |
| Start date | Jan 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Jan 15, 2003 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: